<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Husseiny MMAE</submitter><funding>Vetenskapsrådet</funding><funding>Cancerfonden</funding><pagination>34</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12220533</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Human cells can synthesize methionine from homocysteine and folate-coupled methyl groups via the B&lt;sub>12&lt;/sub>-dependent enzyme methionine synthase (MTR). Yet, it has been known for decades that cancer cells fail to grow when methionine is replaced by homocysteine, a phenomenon known as methionine dependence. The underlying mechanism remains unknown.&lt;h4>Methods&lt;/h4>Cancer cell lines were cultured with homocysteine in place of methionine, and growth responses were measured. Revertant cells capable of growing in homocysteine were generated through long-term culture with high B&lt;sub>12&lt;/sub> and analyzed using single-cell RNA-seq. Metabolite uptake/release was measured using isotope dilution and MTR activity was assessed using metabolic flux analysis (MFA). Functional rescu</pubmed_abstract><journal>Cancer &amp; metabolism</journal><pubmed_title>The role of B&amp;lt;sub&amp;gt;12&amp;lt;/sub&amp;gt; deficiency and methionine synthase in methionine-dependent cancer cells.</pubmed_title><pmcid>PMC12220533</pmcid><funding_grant_id>20 0974 PjF</funding_grant_id><funding_grant_id>2020-01631</funding_grant_id><pubmed_authors>Husseiny MMAE</pubmed_authors><pubmed_authors>Nilsson R</pubmed_authors></additional><is_claimable>false</is_claimable><name>The role of B&amp;lt;sub&amp;gt;12&amp;lt;/sub&amp;gt; deficiency and methionine synthase in methionine-dependent cancer cells.</name><description>&lt;h4>Background&lt;/h4>Human cells can synthesize methionine from homocysteine and folate-coupled methyl groups via the B&lt;sub>12&lt;/sub>-dependent enzyme methionine synthase (MTR). Yet, it has been known for decades that cancer cells fail to grow when methionine is replaced by homocysteine, a phenomenon known as methionine dependence. The underlying mechanism remains unknown.&lt;h4>Methods&lt;/h4>Cancer cell lines were cultured with homocysteine in place of methionine, and growth responses were measured. Revertant cells capable of growing in homocysteine were generated through long-term culture with high B&lt;sub>12&lt;/sub> and analyzed using single-cell RNA-seq. Metabolite uptake/release was measured using isotope dilution and MTR activity was assessed using metabolic flux analysis (MFA). Functional rescu</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jul</publication><modification>2026-07-15T08:59:39.948Z</modification><creation>2026-07-03T03:11:10.335Z</creation></dates><accession>S-EPMC12220533</accession><cross_references><pubmed>40605016</pubmed><doi>10.1186/s40170-025-00405-2</doi></cross_references></HashMap>